FDA Inspection 867768 — Janssen Pharmaceuticals, Inc.

Janssen Pharmaceuticals, Inc. — FEI 1033845

The FDA completed an inspection of Janssen Pharmaceuticals, Inc. on February 20, 2014 in Athens, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 20, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Athens, GA (United States)